Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.
Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check50 days agoChange DetectedThe study has expanded to include 18 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.4%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website was last updated on July 5, 2024, with the previous estimated update date removed.SummaryDifference0.2%
- Check68 days agoChange DetectedThe website now includes new criteria for participant screening and enrollment in study 718-CIH-301, extending the study duration to up to 48 months from the previous 365 days.SummaryDifference4%
Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.